Company / Return on Assets (ROA)
Protalix BioTherapeutics, Inc. Return on Assets (ROA) History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
10.1%
FY2025
5-year range
-32.7% / 10.1%
FY2021-FY2025
Trend
+149.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -183.8% in FY2019 to 80.4% in FY2017.
Based on SEC 10-K filings.
10.1% in FY2025 with a 10-year CAGR of +38.7%.
Improved from -32.7% to 10.1% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +21.8pp
- 5-Year Change
- +49.0pp
- 10-Year Change
- +38.7pp
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 149.6% year-over-year.
- Peak return on assets (roa) was recorded in FY2017.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 10.1% | +149.6% |
| FY2024 | -20.3% | +37.8% |
| FY2023 | -32.7% | -179.5% |
| FY2022 | -11.7% | +52.9% |
| FY2021 | -24.8% | +36.3% |
| FY2020 | -39.0% | +78.8% |
| FY2019 | -183.8% | -328.7% |
| FY2017 | 80.4% | +320.7% |
| FY2016 | -36.4% | -27.4% |
| FY2015 | -28.6% | -92.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026